| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.097 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |